Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: March 2015

Workgroups: Immunization and Infectious Diseases Workgroup

The Advisory Committee on Immunization Practices (ACIP) recommends the Gardasil 9 vaccine as one of 3 vaccines to be used to prevent HPV (human papillomavirus). ACIP recommends HPV vaccination for groups including:

  • Children ages 11 or 12 years 
  • Females ages 13 to 26 years and males ages 13 to 21 years who haven’t been vaccinated before
  • Other high-risk populations who haven’t been vaccinated
Read more about this resource

Objectives related to this resource (1)

Reduce infections of HPV types prevented by the vaccine in young adults — IID‑07
Baseline only

Suggested Citation

1.

Petrosky, E., Bocchini, J.A., Hariri, S., Chesson, H., Curtis, R., Saraiya, M.,...Markowitz, L.E. (2015). Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm